Antibiotic therapy and metabolism in lung cancer patients receiving checkpoint inhibitors

被引：0
|
作者：
Castello, Angelo [1 ]
Rossi, Sabrina [2 ]
Toschi, Luca [3 ]
Lopci, Egesta [2 ]
机构：
[1] Ist Clin Humanitas, Rozzano, MI, Italy
[2] Humanitas Res Hosp, Rozzano, Italy
[3] Humanitas Clin & Res Ctr, Rozzano, MI, Italy
来源：
JOURNAL OF NUCLEAR MEDICINE | 2020年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
238
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Analysis of immune checkpoint inhibitors for advanced non-small cell lung cancer in patients receiving antacids
    Isono, Taisuke
    Furuno, Hajime
    Onodera, Yoko
    Maruyama, Tomoya
    Takeuchi, Yuki
    Kojima, Ayaka
    Nishida, Takashi
    Kobayashi, Yoichi
    Ishiguro, Takashi
    Takaku, Yotaro
    Kurashima, Kazuyoshi
    Kagiyama, Naho
    RESPIRATORY INVESTIGATION, 2024, 62 (06) : 951 - 959
  • [42] Antibiotic Treatment and Immune Checkpoint Inhibitor Therapy in Patients With Cancer
    Yang, Zhenyu
    Wei, Shiyou
    Liu, Lunxu
    JAMA ONCOLOGY, 2020, 6 (04) : 587 - 587
  • [43] Immune checkpoint inhibitors as adjuvant therapy in patients with completely resected nonsmall cell lung cancer
    Pirker, Robert
    CURRENT OPINION IN ONCOLOGY, 2024, 36 (01) : 24 - 28
  • [44] Validation of risk assessment scores in predicting venous thromboembolism in patients with lung cancer receiving immune checkpoint inhibitors
    Zhang, Jiarui
    Xie, Yufang
    Yang, Linhui
    Yang, Mengzhu
    Xu, Rui
    Liu, Dan
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [45] Advances in immune checkpoint inhibitors therapy for small cell lung cancer
    Li, Longhui
    Liang, Yangyueying
    Yu, Minghui
    Zhao, Lu
    Mei, Qingyun
    Yu, Yongchao
    Wang, Na
    Zhang, Dou
    Wang, Ziwei
    Jia, Yingjie
    Kong, Fanming
    CANCER MEDICINE, 2023, 12 (10): : 11097 - 11106
  • [46] AKI in Patients Receiving Immune Checkpoint Inhibitors
    Perazella, Mark A.
    Sprangers, Ben
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (07): : 1077 - 1079
  • [47] Survival outcomes of patients with non-small cell lung cancer concomitantly receiving proton pump inhibitors and immune checkpoint inhibitors
    Baek, Yeon-Hee
    Kang, Eun Joo
    Hong, Soojung
    Park, So-Hee
    Kim, Ju Hwan
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 409 - 410
  • [48] Survival outcomes of patients with non-small cell lung cancer concomitantly receiving proton pump inhibitors and immune checkpoint inhibitors
    Baek, Yeon-Hee
    Kang, Eun Joo
    Hong, Soojung
    Park, So-Hee
    Kim, Ju Hwan
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 347 - 347
  • [49] Immune checkpoint inhibitors in lung cancer
    Koleczko, S.
    Wolf, J.
    INTERNIST, 2020, 61 (07): : 676 - 681
  • [50] Clinical Predictors of Treatment Efficacy in Patients with Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors
    Hu, F.
    Peng, J.
    Niu, Y.
    Mao, X.
    Gu, A.
    Zhao, Y.
    Jiang, L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S354 - S355
12345